Introduction
============

Hypophysitis is a chronic inflammation of the pituitary gland of complex and still incompletely defined pathogenesis. It belongs to the group of non-hormone-secreting sellar masses, sharing with them comparable clinical presentation and radiographic appearance. These similarities often make it difficult to establish a diagnosis with certainty before pituitary surgery and pathologic examination of the resected pituitary tissue.[@JR0178-1] Immunoglobulin G4 (IgG4)-related diseases, including IgG4-related hypophysitis, are recently characterized entities marked by elevated serum IgG4 levels and tissue infiltration by IgG4-positive plasma cells.[@JR0178-2] [@JR0178-3] It was first diagnosed on clinical grounds in 2004[@JR0178-4] and then by pathology in 2007.[@JR0178-5] We reported a patient with IgG4-related hypophysitis and summarize the current relevant literature.

Review of Literature
====================

Hypophysitis has been classified in several ways based on anatomic location of the pituitary involvement, cause, and histopathologic appearance ([Table 1](#TB0178-1){ref-type="table"}).[@JR0178-6]

###### Current classifications of hypophysitis

  ----------------------------------------------------------------------------------------
  Based on the anatomic location of pituitary involvement

   Adenohypophysitis

   Infundibuloneurohypophysitis

   Panhypophysitis

  Based on the histologic appearance

   Lymphocytic

   Granulomatous

   Xanthomatous

   Necrotizing

   Immunoglobulin G4 plasmacytic

   Mixed forms (lymphogranulomatous, xanthogranulomatous)

  Based on the cause

   Primary (isolated or as part of a multiorgan systemic disease)

   Secondary to:

    Sellar diseases (germinoma, Rathke cleft cyst, craniopharyngioma, pituitary adenoma)

    Systemic diseases (Wegener\'s granulomatosis, tuberculosis, sarcoidosis, syphilis)\
    Injection of immunomodulatory drugs (CTLA-4 blocking antibody, interferon-alpha)
  ----------------------------------------------------------------------------------------

Abbreviation: CTLA-4, T-lymphocyte-associated protein-4.

Note: Adapted of Leporati et al.[@JR0178-6]

When surgery of the pituitary gland is performed, the pituitary pathology reveals two more common forms (lymphocytic and granulomatous) and three rarer variants (xanthomatous, necrotizing, and IgG4-producing plasma cells).[@JR0178-6] IgG4-related hypophysitis was first reported in 2004 in a 66-year-old woman with multiple pseudotumors in the salivary glands, pancreas, and retroperitoneum,[@JR0178-4] and then the entity was more extensively described in 2006 in a 70-year-old man with swelling of the salivary glands caused by a marked infiltration with lymphocytes and IgG4-positive plasma cells.[@JR0178-7] Since the first IgG4-related hypophysitis case was described in 2004, more than 20 histogenetically proven cases have been reported, mostly from Japan.[@JR0178-8] [@JR0178-9] [@JR0178-10] [@JR0178-11] All were accompanied by complications of pituitary insufficiency, but Hattori et al described the first case of IgG4-related hypophysitis without pituitary insufficiency.[@JR0178-12] Our patient had pituitary insufficiency.

This disease is typically part of a multifocal systemic disease recently called "IgG4-related autoimmune disease,"[@JR0178-13] which emphasizes the contribution of IgG4 in establishing the diagnosis.[@JR0178-6] IgG4, the least abundant of the four IgG antibodies, has long been associated with autoimmune and allergic diseases.[@JR0178-14] IgG4 antibodies were ignored for diagnostic purposes until 2001, when Hamano et al linked them to autoimmune pancreatitis and made it possible to recognize that many diseases associated with autoimmune pancreatitis share similar pathologic features, thus defining the existence of a multifocal systemic disease.[@JR0178-15] At the present time, the pathogenetic mechanism and underlying immunologic abnormalities remain unclear.[@JR0178-16] A recent report identified autoimmune antibodies against GH (growth hormone) and adrenocorticotropic hormone in a patient with IgG4-related hypophysitis.[@JR0178-17] Nonetheless, collecting further evident cases and analysis is required to characterize the pathophysiology of IgG4-related hypophysitis.[@JR0178-12]

Leporati et al suggested five criteria to diagnose IgG4-related hypophysitis: (1) pituitary histopathology, (2) magnetic resonance imaging (MRI) of the pituitary, (3) biopsy-proven involvement in other organs, (4) serology with increased serum IgG4, and (5) response to glucocorticoids.[@JR0178-6] Leporati et al also proposed that the diagnosis of IgG4-related hypophysitis is established when any of the following is fulfilled: criterion 1 alone or criteria 2 + 3 or criteria 2 + 4 + 5 ([Table 2](#TB0178-2){ref-type="table"}).[@JR0178-6] According to the criteria, a pituitary biopsy is not essential; however, there have been eight cases diagnosed by pituitary biopsy. Our patient fulfilled two diagnostic criteria suggested by Leporati et al to be associated with mass in the sphenoidal sinus and complication of pituitary insufficiency.

###### Diagnostic criteria for IgG4-related hypophysitis

  ----------------------------------------------------------------------------------------------------------------------------------------------------
  Criterion 1: Pituitary histopathology
   Mononuclear infiltration of the pituitary gland, rich in lymphocytes and plasma cells, with more than 10 IgG4-positive cells per high-power field
  Criterion 2: Pituitary MRI
   Sellar mass and/or thickened pituitary stalk
  Criterion 3: Biopsy-proven involvement in other organs
   Association with IgG4-positive lesions in other organs
  Criterion 4: Serology
   Increased serum IgG4 (\>140 mg/dL)
  Criterion 5: Response to glucocorticoids
  Shrinkage of the pituitary mass and symptom improvement with steroids
  Diagnosis of IgG4-related hypophysitis is established when any of the following is fulfilled:
  Criterion 1 OR
  Criteria 2 and 3 OR
  Criteria 2, 4, and 5
  ----------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: IgG4, immunoglobulin G4; MRI, magnetic resonance imaging.

Note: Adapted from Leporati et al.[@JR0178-6]

Case Report
===========

A 40-year-old man with diagnosis of central diabetes insipidus since 2001, using oral desmopressin 0.3 mg/d, complained of frontal headache, sexual impotence, and decrease in libido. Endocrine assessment in 2003 revealed low levels of testosterone and gonadotropins and decreased insulin-like growth factor 1 (IGF-1) serum ([Table 3](#TB0178-3){ref-type="table"}). The patient was treated with replacement therapy of testosterone decanoate 250 mg injections every 21 days and sexual impotence and libido improved.

###### Endocrine assessment

  Hormones             Year    Reference range   
  -------------------- ------- ----------------- -----------------
  Cortisol             19.9    12.4              5--25 μg/dL
  IGF-1                154     83                128--327 ng/mL
  GH                   \<0.1   \<0.1             Up to 4.4 ng/mL
  TSH                  1.2     1.73              0.27--4.2 μU/mL
  Free T4              0.9     0.94              0.9--1.70 ng/dL
  Prolactin            4.6     5.1               4--15.2 ng/mL
  FSH                  5.2     \<0.6             1.5--12.4 IU/L
  LH                   3.3     \<0.1             1.7--8.6 IU/L
  Total testosterone   246     87                249--836 ng/dL

Abbreviations: FSH, follicle-stimulating hormone; GH, growth hormone; IGF-1, insulin-like growth factor-1; LH, luteinizing hormone; TSH, thyroid-stimulating hormone.

In 2005, MRI revealed a centered pituitary stalk with focal nodular thickening measuring 6 mm at the lower portion characterized by isointensity on T1-weighted images, hypointensity on T2-weighted images, and a heterogeneous intense enhancement after gadolinium administration. Heterogeneous materials inside the sphenoidal sinus were also present ([Fig. 1](#FI0178-1){ref-type="fig"}).

![Magnetic resonance imaging showing thickening of the stalk and presence of heterogeneous materials inside sphenoid sinus. (A) T1-weighted coronal image without gadolinium. (B) T1-weighted coronal image with gadolinium.](10-1055-s-0034-1397333-i0178-1){#FI0178-1}

MRIs from 2008, 2010, and 2011 showed no changes on the images.

In 2012, based on the clinical and radiologic findings, a diagnosis of autoimmune hypophysitis with associated sinusitis was suspected. We observed unreactive levels of autoimmune antibodies, including anti-Sjögren syndrome antigen A (anti SS-A/Ro) and antigen B (anti SS-B/La) antibodies, ANA (antinuclear antibody) anti-Sm, rheumatoid factor, thyroglobulin, thyroperoxidase, and parietal cell. Adenosine deaminase, angiotensin I-converting enzyme, and tumor markers were negative. In 2013, there was elevation of gonadotropins, IGF-1, and total testosterone levels ([Table 3](#TB0178-1){ref-type="table"}). Laboratory results revealed the following: serum IgG, 1,644 mg/dL (reference range 952 to 1,538 mg/dL), and serum IgG4, 2,040 mg/dL (reference range 84 to 888 mg/dL). IgG4 was titled in two different analyses. The patient\'s test results strongly favored a diagnosis of IgG4-related hypophysitis.

Discussion
==========

IgG4 serum levels are typically elevated in IgG4-related hypophysitis, similar to our patient, but they can decrease after glucocorticoid therapy initiation and in later disease stages. The involvement of the sphenoidal sinus is yet another manifestation of the multifocal IgG4-related autoimmune disease.[@JR0178-6] Our patient showed a concomitant involvement of both pituitary and sphenoidal tissues, showing that hypophysitis by IgG4 should be in the differential diagnosis of masses in the sphenoid sinus.

The typical therapy for IgG4-related hypophysitis is undefined; however, glucocorticoids are recommended as a first-line therapy against IgG4-related disease.[@JR0178-10] On the basis of treatment of autoimmune pancreatitis, an initial oral prednisolone dose of 0.6 mg/kg for 2 to 4 weeks is suggested, tapered by 5 mg every 1 to 2 weeks for 2 to 3 months to determine a maintenance dose (2.5 to 5 mg/d), which should be discontinued within 3 years.[@JR0178-10] [@JR0178-13]

Final Comments
==============

IgG4-related hypophysitis should be considered in patients with pituitary insufficiency associated with sellar mass and/or thickened pituitary stalk. The presence of a mass in the sphenoidal sinus together with the thickening of the pituitary stalk could also suggest IgG4 hypophysitis. Furthermore, IgG4 serum measurement for early diagnosis of IgG4-related hypophysitis should be performed. Finally, a correct diagnosis is critical because it can spare the patient from a major surgery for a disease that responds well to glucocorticoids.
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